Skip to main content
OpenTrials
Completed

NCT Number: NCT00372645

Increasing Folate Status of a General Population(FOLSUPP STUDY)

The aim of this study is to determine the best source of folate to raise the folate status of a general population over a 16 week intervention period.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Institute of Food Research, Norwich, Norfolk, United Kingdom

Loading trial locations.

About this study

This study is designed to assess whether increasing the consumption of natural food folates from a mixed diet is as effective as supplemental folic acid or supplemental natural folate in raising folate status, reducing biomarkers of cardio vascular disease (CVD) risk, and improving vascular function. Randomised placebo-controlled parallel studies will be undertaken in groups of individuals in Norwich and Sheffield. There will be four treatment arms: a) 200 µg folate per day from folate-rich foods, b) 200 µg folate per day from supplemental folic acid, c) 200 µg folate per day from supplemental Metafolin® (6S 5-methyltetrahydrofolic acid) and d) a placebo group. Results from the two centres will be combined, thus ensuring a wide population is covered. Folate status, biomarkers of CVD risk and vascular function (pulse wave velocity) will be measured before and following the intervention period of 16 weeks, together with possible confounders (such as vitamins B2 & B12 status, and MTHFR genotype). 7-Day weighed intakes will be used to measure habitual B-vitamin intake during baseline and intervention, to determine changes in folate intake and assist compliance. Additionally, folate content of selected folate-rich foods will be determined for each volunteer. The results will aid the Food Standards Agency (FSA) in formulating public health policy related to improving folate status and reducing CVD risk.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Men and women aged 18-65 years
  • Smokers and non-smokers

Exclusion criteria

  • Pregnant or has been pregnant within the last 12 months
  • Breastfeeding
  • Has donated or intends to donate blood within 16 weeks of the first or last study samples
  • Fails standard clinical screening of blood and urine for human studies at the Institute of Food Reseach
  • BMI above 18 or below 40
  • Receiving vascular disease or anti-hypertensive drugs
  • Those with diabetes
  • Regularly consuming dietary supplements containing B-vitamins and/or folic acid.

[As the capsules are prepared from gelatin, true vegetarians may not wish to participate]

Treatment and study plan

Folic acid (supplement)

Dietary Supplement

200 µg folate per day from supplemental folic acid

Metafolin (supplement)

Dietary Supplement

200 µg folate per day from supplemental Metafolin®

Placebo

Drug

Placebo

Folate rich foods

Other

200 µg folate per day from folate-rich foods

Primary outcomes

  1. Folate status

    Time frame: Baseline and 16 weeks

  2. Homocysteine status

    Time frame: Baseline and 16 weeks

Secondary outcomes

  1. Cardio vascular disease markers

    Time frame: Baseline and 16 weeks

  2. Inflammatory markers

    Time frame: Baseline and 16 weeks

  3. Pulse wave velocity

    Time frame: Baseline and 16 weeks

Sponsors and collaborators

Lead sponsor

Quadram Institute Bioscience

Other

Collaborators

  • Food Standards Agency, United Kingdom
  • University of Sheffield

Registry information

Official study title

Effects Of A Mixed Diet Intervention Versus Folic Acid Supplementation And Metafolin® Supplementation On Folate Status And Cardiovascular Disease Risk Factors In Healthy Adults

Important dates

Study start
2005
Primary completion
2008
Study completion
2012
First posted
Sep 7, 2006
Registry last updated
Mar 24, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.